Parallel Advisors’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Parallel Advisors’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55	Sell	3 -1	-25%	-$23	﹤0.01%	3891
2026 Q1	$81	Buy	4 +3	+300%	+$602	﹤0.01%	3789
2025 Q4	$988	Hold	1	–	–	﹤0.01%	3299
2025 Q3	$481	Hold	1	–	–	﹤0.01%	3337
2025 Q2	$487	Hold	1	–	–	﹤0.01%	3307
2025 Q1	$392	Hold	1	–	–	﹤0.01%	3276
2024 Q4	$552	Hold	1	–	–	﹤0.01%	3208
2024 Q3	$229	Hold	1	–	–	﹤0.01%	3291
2024 Q2	$221	Sell	1 -1	-50%	-$181	﹤0.01%	3193
2024 Q1	$330	Sell	2 -10	-83%	-$2.48K	﹤0.01%	3101
2023 Q4	$2.5K	Hold	12	–	–	﹤0.01%	2735
2023 Q3	$2.66K	Hold	12	–	–	﹤0.01%	2727
2023 Q2	$3.58K	Hold	12	–	–	﹤0.01%	2551
2023 Q1	$3.71K	Hold	12	–	–	﹤0.01%	2527
2022 Q4	$1.56K	Hold	12	–	–	﹤0.01%	2777
2022 Q3	$3K	Hold	12	–	–	﹤0.01%	2521
2022 Q2	$5K	Buy	12 +4	+50%	+$2.83K	﹤0.01%	2280
2022 Q1	$10K	Hold	8	–	–	﹤0.01%	2035
2021 Q4	$21K	Sell	8 -3	-27%	-$18.3K	﹤0.01%	1756
2021 Q3	$196K	Buy	11 +5	+83%	+$79.5K	0.01%	726
2021 Q2	$66K	Buy	6 +1	+20%	+$8.38K	﹤0.01%	1109
2021 Q1	$34K	Hold	5	–	–	﹤0.01%	1352
2020 Q4	$26K	Hold	5	–	–	﹤0.01%	1377
2020 Q3	$47K	Hold	5	–	–	﹤0.01%	1091
2020 Q2	$43K	Hold	5	–	–	﹤0.01%	1109
2020 Q1	$43K	Buy	+5	New	+$49.4K	﹤0.01%	1006

Other funds holding IRLA

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parallel Advisors's IRLA Position: Q2 2026 in Review

Parallel Advisors reduced its IRulya Therapeutics Inc. Common Stock (IRLA) stake by 25% in Q2 2026, selling an estimated $23 and leaving 3 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #3891.

Parallel Advisors first reported a position in IRLA in Q1 2020 and has held it in 26 quarters since. The position peaked at $196K in Q3 2021. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

Parallel Advisors held 3 shares of IRulya Therapeutics Inc. Common Stock worth $55 as of Q2 2026.
Parallel Advisors sold 1 IRulya Therapeutics Inc. Common Stock share in Q2 2026, an estimated $23.
IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3891 holding.
Parallel Advisors first reported a position in IRulya Therapeutics Inc. Common Stock in Q1 2020 and has held it in 26 quarters since.
Parallel Advisors's IRulya Therapeutics Inc. Common Stock position peaked at $196K in Q3 2021.
26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.